Howard E. Gendelman

Active 1983–2025

212
Papers
37,643
Citations
110
h-index
207
i10-index

Citations

Citations per year for Howard E. Gendelman1970: 1 citations1979: 2 citations1985: 8 citations1986: 27 citations1987: 67 citations1988: 101 citations1989: 131 citations1990: 128 citations1991: 112 citations1992: 168 citations1993: 139 citations1994: 148 citations1995: 167 citations1996: 207 citations1997: 190 citations1998: 252 citations1999: 265 citations2000: 190 citations2001: 204 citations2002: 210 citations2003: 201 citations2004: 177 citations2005: 222 citations2006: 211 citations2007: 199 citations2008: 292 citations2009: 368 citations2010: 336 citations2011: 315 citations2012: 330 citations2013: 359 citations2014: 343 citations2015: 289 citations2016: 299 citations2017: 288 citations2018: 287 citations2019: 804 citations2020: 936 citations2021: 1,060 citations2022: 1,001 citations2023: 735 citations2024: 954 citations2025: 420 citations2026: 11 citations1971–1978: no citations, so these years are not shown1980–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,772 citing papers, 36.2% of this breakdownChina: 1,166 citing papers, 8.8% of this breakdownUnited Kingdom: 687 citing papers, 5.2% of this breakdownGermany: 522 citing papers, 4% of this breakdownIndia: 471 citing papers, 3.6% of this breakdownFrance: 442 citing papers, 3.4% of this breakdownItaly: 427 citing papers, 3.2% of this breakdownCanada: 409 citing papers, 3.1% of this breakdownAustralia: 348 citing papers, 2.6% of this breakdownJapan: 282 citing papers, 2.1% of this breakdownSpain: 262 citing papers, 2% of this breakdownSouth Korea: 250 citing papers, 1.9% of this breakdown
0%36.2%Other 23.9%

Fields

  • Immunology and Microbiology29.8%
  • Medicine28.8%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Neuroscience14.7%
  • Materials Science2.5%
  • Engineering1.8%
  • Other5%

Topics

  • HIV Research and Treatment9.9%
  • Neuroinflammation and Neurodegeneration Mechanisms6.8%
  • Alzheimer's disease research and treatments3.3%
  • HIV/AIDS drug development and treatment3.2%
  • Parkinson's Disease Mechanisms and Treatments2.7%
  • Immune Cell Function and Interaction2.5%
  • Other71.6%

Coauthors

All papers

Open in search
  1. The 2022 outbreak and the pathobiology of the monkeypox virus

    Authors: , , , - Journal of Autoimmunity 2022 cited by 520

  2. Diagnostics for SARS-CoV-2 infections

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Materials 2021 cited by 842

  3. Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons

    Authors: , , , , , , , , , , , , , , , , - Brain 2020 cited by 276

  4. Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues

    Authors: , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2020 cited by 195

  5. CD4+ effector T cells accelerate Alzheimer’s disease in mice

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Neuroinflammation 2021 cited by 150

  6. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

    Authors: , , , , , , - Journal of Virology 1986 cited by 2,900

  7. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders

    Authors: , , , , , , - Molecular Neurodegeneration 2020 cited by 129

  8. CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease

    Authors: , , , , , , , , , , , , , - Journal of Neuroimmune Pharmacology 2012 cited by 324

  9. Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

    Authors: , , , , , , , , , , , , - Molecular Neurodegeneration 2023 cited by 73

  10. A call for transparent reporting to optimize the predictive value of preclinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steve Perrin, John D. Porter, Oswald Steward, Ellis F. Unger, Ursula Utz, Shai D. Silberberg - Nature 2012 cited by 1,224

  11. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kamel Khalili, Howard E. Gendelman - Nature Communications 2019 cited by 296

  12. Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease

    Authors: , , , , , - The Journal of Immunology 2010 cited by 407

  13. CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 76

  14. Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic Mice

    Authors: , , , , , , - American Journal Of Pathology 2007 cited by 361

  15. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections

    Authors: , , , , , , , , , , , , , , - Journal of Neuroimmune Pharmacology 2020 cited by 626

  16. Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease

    Authors: , , , , , , , - Clinical Neuroscience Research 2006 cited by 389

  17. Cell-mediated drug delivery

    Authors: , , - Expert Opinion on Drug Delivery 2011 cited by 315

  18. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease

    Authors: , , , , - Journal of Leukocyte Biology 2007 cited by 434

  19. Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons

    Authors: , , , , , , , , , , - PLoS ONE 2008 cited by 361

  20. A year-long extended release nanoformulated cabotegravir prodrug

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Materials 2020 cited by 110

  21. Oxidative Stress and the Pathogenesis of Neurodegenerative Disorders

    Authors: , , , - International review of neurobiology 2007 cited by 432

  22. Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy

    Authors: , , , , , , , , , - Science 1986 cited by 1,699

  23. Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 435

  24. Biochemical and Biologic Characterization of Exosomes and Microvesicles as Facilitators of HIV-1 Infection in Macrophages

    Authors: , , , , - The Journal of Immunology 2012 cited by 237